1. Home
  2. CSTE vs ACET Comparison

CSTE vs ACET Comparison

Compare CSTE & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.74

Market Cap

60.2M

Sector

Industrials

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.48

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
ACET
Founded
1987
1947
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
71.3M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CSTE
ACET
Price
$1.74
$8.48
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$5.00
$136.00
AVG Volume (30 Days)
142.0K
201.2K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$7.15
52 Week High
$4.67
$17.76

Technical Indicators

Market Signals
Indicator
CSTE
ACET
Relative Strength Index (RSI) 55.94 97.99
Support Level $1.65 $0.47
Resistance Level $2.05 $8.84
Average True Range (ATR) 0.18 0.18
MACD -0.01 0.93
Stochastic Oscillator 46.91 94.87

Price Performance

Historical Comparison
CSTE
ACET

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: